marketcaparena
Search

    IBIO

    iBio, Inc.

    Company overview

    Market capitalization
    $75.24M
    Employees
    20
    Latest publication
    2026-09-29
    About iBio, Inc.

    iBio, Inc., a preclinical stage biotechnology company, engages in the development of artificial intelligence (AI) antibodies solutions for cardiometabolic and obesity space. The company's technology platforms include EngageTx that provides improved CD3 T-cell engager antibody panel; ShieldTx, an antibody masking technology that enables the creation of conditionally activated antibodies; StableHu, an AI antibody-optimizing technology; and AI epitope steering technology that guides antibodies against the desired regions of the target protein. Its product pipelines for cardiometabolic disease area include IBIO-101, an anti-CD25 Mab that binds and depletes immunosuppressive regulatory treg cells to inhibit the growth of solid tumors; CCR8, an antibody that enhance the body's immune response against cancer cells; and MUC16 antibodies. In addition, the company is developing EGFRvIII, an antibody therapeutics that targets EGFRvIII protein with the aim to address these cancer types without affecting healthy cells; and TROP-2 x CD3 bispecific antibody that is developed with EngageTx platform to harness T cells to kill TROP-2"expressing tumors while minimizing the cytokine release that often limits the tolerability of T-cell engagers. It has a collaboration agreement with AstralBio to discover and develop novel antibodies for obesity and other cardiometabolic diseases. The company was formerly known as iBioPharma, Inc. and changed its name to iBio, Inc. in August 2009. iBio, Inc. was incorporated in 2008 and is headquartered in San Diego, California.

    Company website

    Financial statements

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Total Revenue100,000USD400,000USD225,000USD50,000USD1,884,000USD2,371,000USD1,638,000USD2,018,000USD
    Research Development19,643,000USD8,312,000USD5,185,000USD10,327,000USD9,827,000USD9,989,000USD3,573,000USD5,474,000USD
    Selling General Administrative10,595,000USD10,690,000USD11,674,000USD19,016,000USD21,754,000USD21,699,000USD11,365,000USD12,332,000USD
    General And Administrative Expenses10,595,000USD———————
    Total Operating Expenses35,241,000USD19,002,000USD16,859,000USD29,343,000USD27,790,000USD32,020,000USD14,938,000USD17,806,000USD
    Operating Income-35,141,000USD-18,602,000USD-16,634,000USD-29,311,000USD-29,697,000USD-31,111,000USD-14,003,000USD-15,788,000USD
    Total Other Income Expense Net2,097,000USD225,000USD1,191,000USD-98,000USD184,000USD7,898,000USD-2,441,000USD-1,809,000USD
    Interest Income2,150,000USD437,000USD363,000USD213,000USD178,000USD140,000USD15,000USD75,000USD
    Interest Expense53,000USD212,000USD172,000USD83,000USD1,412,000USD2,454,000USD2,466,000USD1,900,000USD
    Income Before Tax-33,044,000USD-18,377,000USD-15,443,000USD-29,311,000USD-29,513,000USD-23,213,000USD-16,444,000USD-17,597,000USD
    Income Tax Expense0USD—9,636,000USD-1,204,000USD701,000USD46,000USD2,471,000USD-4,000USD
    Net Income-33,044,000USD-18,377,000USD-24,907,000USD-29,311,000USD-50,391,000USD-23,207,000USD-16,439,000USD-17,593,000USD
    Net Income Applicable To Common Shares-33,044,000USD——-65,010,000USD-50,391,000USD-23,467,000USD-38,260,000USD-17,853,000USD
    Gross Profit—400,000USD225,000USD50,000USD-1,907,000USD909,000USD935,000USD2,018,000USD
    Net Interest Income—225,000USD191,000USD130,000USD-1,234,000USD-2,314,000USD-2,451,000USD-1,825,000USD
    Net Income From Continuing Ops—-18,377,000USD-15,443,000USD-29,311,000USD-50,304,000USD-23,213,000USD-16,444,000USD-17,597,000USD
    Ebit—-18,165,000USD-15,271,000USD-29,311,000USD-29,513,000USD-30,968,000USD-13,978,000USD-15,697,000USD
    Ebitda—-17,039,000USD-14,021,000USD-28,107,000USD-25,722,000USD-28,554,000USD-11,737,000USD-13,948,000USD
    Depreciation And Amortization—1,126,000USD1,250,000USD1,204,000USD3,791,000USD2,414,000USD2,241,000USD1,749,000USD
    Reconciled Depreciation—1,126,000USD1,250,000USD1,380,000USD3,791,000USD2,414,000USD2,241,000USD1,749,000USD
    Cost Of Revenue——1,250,000USD1,106,000USD3,791,000USD1,462,000USD703,000USD—
    Minority Interest———0USD1,000USD-17,000USD-5,000USD-4,000USD
    Discontinued Operations———-35,699,000USD-20,791,000USD-20,791,000USD-20,791,000USD—
    Unclassified Operating Expenses————-3,791,000USD———
    Selling And Marketing Expenses—————189,000USD——
    Non Operating Income Net Other——————25,000USD91,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USDQ4 20242024-06-30 · USD
    Total Revenue0USD0USD100,000USD200,000USD0USD200,000USD0USD175,000USD
    Cost Of Revenue250,000USD241,000USD289,000USD————281,000USD
    Gross Profit-250,000USD-241,000USD-189,000USD200,000USD—200,000USD—-106,000USD
    Research Development3,254,000USD4,280,000USD3,550,000USD3,224,000USD1,906,000USD1,877,000USD1,305,000USD1,140,000USD
    Selling General Administrative5,111,000USD5,165,000USD2,501,000USD2,174,000USD2,973,000USD2,742,000USD2,801,000USD2,444,000USD
    Unclassified Operating Expenses-2,753,000USD-2,741,000USD——————
    Total Operating Expenses5,612,000USD6,704,000USD5,762,000USD5,398,000USD4,879,000USD4,619,000USD4,106,000USD3,303,000USD
    Operating Income-5,862,000USD-6,945,000USD-5,951,000USD-5,198,000USD-4,879,000USD-4,419,000USD-4,106,000USD-3,409,000USD
    Interest Income657,000USD493,000USD267,000USD79,000USD72,000USD112,000USD174,000USD223,000USD
    Interest Expense22,000USD41,000USD36,000USD44,000USD54,000USD57,000USD57,000USD60,000USD
    Net Interest Income635,000USD452,000USD231,000USD35,000USD18,000USD55,000USD117,000USD163,000USD
    Income Before Tax-7,730,000USD-8,993,000USD-5,720,000USD-5,163,000USD-4,861,000USD-4,364,000USD-3,989,000USD-3,246,000USD
    Net Income-7,730,000USD-8,993,000USD-5,720,000USD-5,163,000USD-4,861,000USD-4,364,000USD-3,989,000USD-7,778,000USD
    Net Income From Continuing Ops-7,730,000USD-8,993,000USD-5,720,000USD-5,163,000USD-4,861,000USD-4,364,000USD-3,989,000USD-3,246,000USD
    Ebit-5,862,000USD-6,945,000USD-5,684,000USD-5,119,000USD-4,807,000USD-4,307,000USD-3,932,000USD-3,186,000USD
    Ebitda-5,612,000USD-6,704,000USD-5,395,000USD-4,834,000USD-4,525,000USD-4,026,000USD-3,654,000USD-2,905,000USD
    Depreciation And Amortization250,000USD241,000USD289,000USD285,000USD282,000USD281,000USD278,000USD281,000USD
    Reconciled Depreciation250,000USD241,000USD289,000USD285,000USD282,000USD281,000USD278,000USD281,000USD
    Total Other Income Expense Net-1,868,000USD-2,048,000USD231,000USD35,000USD18,000USD55,000USD117,000USD163,000USD
    Income Tax Expense——————-3,989,000USD-1,298,000USD
    Selling And Marketing Expenses———————332,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ4 20262026-06-30 · USDQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USD
    Total Assets99,110,000USD85,834,000USD64,393,000USD64,155,000USD23,185,000USD19,103,000USD21,697,000USD24,517,000USD
    Cash And Equivalents56,395,000USD———————
    Total Current Assets92,221,000USD77,251,000USD53,368,000USD50,772,000USD9,721,000USD6,060,000USD8,285,000USD11,705,000USD
    Other Current Assets3,078,000USD2,454,000USD670,000USD1,140,000USD1,034,000USD1,101,000USD1,257,000USD667,000USD
    Total Liabilities13,397,000USD———————
    Total Current Liabilities11,745,000USD6,504,000USD5,901,000USD6,048,000USD6,106,000USD5,397,000USD4,709,000USD3,469,000USD
    Other Current Liabilities5,626,000USD———————
    Total Stockholder Equity85,713,000USD77,537,000USD56,560,000USD56,039,000USD14,880,000USD11,381,000USD13,895,000USD17,754,000USD
    Total Equity Including Noncontrolling Interest85,713,000USD———————
    Deferred Revenue1,150,000USD———————
    Property Plant Equipment Net4,753,000USD5,076,000USD5,311,000USD5,168,000USD5,282,000USD5,562,000USD5,824,000USD6,099,000USD
    Intangible Assets1,825,000USD1,830,000USD4,338,000USD6,843,000USD6,848,000USD6,103,000USD6,108,000USD5,363,000USD
    Accounts Payable4,423,000USD3,035,000USD2,654,000USD2,822,000USD2,188,000USD1,477,000USD614,000USD855,000USD
    Short Term Debt546,000USD532,000USD518,000USD1,210,000USD1,309,000USD1,430,000USD904,000USD955,000USD
    Common Stock56,000USD35,000USD30,000USD20,000USD19,000USD10,000USD9,000USD9,000USD
    Retained Earnings-365,268,000USD-354,667,000USD-346,937,000USD-337,944,000USD-332,224,000USD-327,061,000USD-322,200,000USD-317,836,000USD
    Accumulated Other Comprehensive Income-45,000USD-21,000USD10,000USD-15,000USD————
    Total Liab—8,297,000USD7,833,000USD8,116,000USD8,305,000USD7,722,000USD7,802,000USD6,763,000USD
    Other Current Liab—1,787,000USD1,579,000USD850,000USD1,409,000USD1,890,000USD2,591,000USD1,259,000USD
    Capital Stock—35,000USD30,000USD20,000USD19,000USD10,000USD9,000USD9,000USD
    Other Assets—1USD——————
    Cash—47,631,000USD28,672,000USD28,111,000USD8,582,000USD4,959,000USD7,015,000USD11,038,000USD
    Cash And Short Term Investments—74,797,000USD52,698,000USD49,567,000USD8,582,000USD4,959,000USD7,015,000USD11,038,000USD
    Current Deferred Revenue—1,150,000USD1,150,000USD1,150,000USD1,200,000USD600,000USD600,000USD400,000USD
    Net Debt—-45,306,000USD-26,222,000USD-24,817,000USD-5,074,000USD-1,204,000USD-3,018,000USD-6,805,000USD
    Short Long Term Debt Total—2,325,000USD2,450,000USD3,294,000USD3,508,000USD3,755,000USD3,997,000USD4,233,000USD
    Short Term Investments—27,166,000USD24,026,000USD21,456,000USD————
    Net Receivables—0USD0USD65,000USD105,000USD—13,000USD—
    Property Plant Equipment Gross—6,983,000USD7,070,000USD6,847,000USD7,523,000USD7,614,000USD7,688,000USD7,774,000USD
    Common Stock Shares Outstanding—119,600,000shares99,133,000shares52,981,000shares16,423,583shares9,862,000shares9,132,000shares8,633,000shares
    Non Current Assets Total—8,582,999USD11,025,000USD13,383,000USD13,464,000USD13,043,000USD13,412,000USD12,812,000USD
    Non Current Liabilities Total—1,793,000USD1,932,000USD2,067,999USD2,199,000USD2,325,000USD3,093,000USD3,294,000USD
    Non Currrent Assets Other—291,999USD10,000USD26,000USD26,000USD1,378,000USD1,480,000USD1,350,000USD
    Net Working Capital—70,747,000USD47,467,000USD44,724,000USD3,615,000USD663,000USD3,576,000USD8,236,000USD
    Unclassified Non Current Assets—1,384,999USD1,366,000USD1,346,000USD1,308,000USD———
    Unclassified Non Current Liabilities—1,793,000USD1,932,000USD2,067,999USD2,199,000USD2,325,000USD2,450,000USD2,588,000USD
    Unclassified Equity—432,155,000USD403,427,000USD393,958,000USD347,066,000USD338,422,000USD336,077,000USD335,572,000USD
    Short Long Term Debt———706,000USD766,000USD824,000USD237,000USD227,000USD
    Long Term Debt——————643,000USD706,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Total Assets99,110,000USD23,185,000USD28,734,000USD41,207,000USD99,406,000USD146,968,000USD94,189,000USD30,586,000USD
    Cash And Equivalents56,395,000USD———————
    Total Current Assets92,221,000USD9,721,000USD15,672,000USD26,259,000USD45,070,000USD104,597,000USD61,748,000USD4,808,000USD
    Other Current Assets3,078,000USD1,034,000USD749,000USD18,729,000USD1,549,000USD2,070,000USD214,000USD290,000USD
    Total Liabilities13,397,000USD———————
    Total Current Liabilities11,745,000USD6,106,000USD3,840,000USD21,582,000USD30,436,000USD6,645,000USD5,236,000USD3,458,000USD
    Other Current Liabilities5,626,000USD———————
    Total Stockholder Equity85,713,000USD14,880,000USD21,324,000USD15,381,000USD63,485,000USD108,585,000USD56,618,000USD2,463,000USD
    Total Equity Including Noncontrolling Interest85,713,000USD———————
    Deferred Revenue1,150,000USD———————
    Property Plant Equipment Net4,753,000USD5,282,000USD6,372,000USD7,551,000USD41,755,000USD34,739,000USD31,273,000USD24,380,000USD
    Intangible Assets1,825,000USD6,848,000USD5,368,000USD5,388,000USD4,851,000USD952,000USD1,144,000USD1,374,000USD
    Accounts Payable4,423,000USD2,188,000USD358,000USD1,849,000USD4,264,000USD2,254,000USD1,759,000USD1,001,000USD
    Short Term Debt546,000USD1,309,000USD953,000USD13,598,000USD22,252,000USD967,000USD562,000USD213,000USD
    Common Stock56,000USD19,000USD9,000USD20,000USD9,000USD9,000USD140,000USD20,000USD
    Retained Earnings-365,268,000USD-332,224,000USD-313,847,000USD-288,940,000USD-223,930,000USD-173,627,000USD-150,420,000USD-105,821,000USD
    Accumulated Other Comprehensive Income-45,000USD———-213,000USD-63,000USD-33,000USD-31,000USD
    Total Liab—8,305,000USD7,410,000USD25,826,000USD35,921,000USD38,400,000USD37,582,000USD28,129,000USD
    Other Current Liab—1,409,000USD2,329,000USD5,867,000USD3,536,000USD2,706,000USD810,000USD582,000USD
    Capital Stock—19,000USD9,000USD20,000USD9,000USD217,000USD140,000USD20,000USD
    Cash—8,582,000USD14,210,000USD7,326,000USD22,676,000USD77,404,000USD55,112,000USD4,421,000USD
    Cash And Short Term Investments—8,582,000USD14,210,000USD7,326,000USD33,521,000USD96,974,000USD55,112,000USD4,421,000USD
    Current Deferred Revenue—1,200,000USD200,000USD4,194,000USD100,000USD423,000USD1,810,000USD1,279,000USD
    Net Debt—-5,074,000USD-9,750,000USD9,748,000USD3,090,000USD-44,682,000USD-22,204,000USD20,463,000USD
    Short Long Term Debt—766,000USD218,000USD12,937,000USD22,161,000USD600,000USD261,000USD—
    Short Long Term Debt Total—3,508,000USD4,460,000USD17,074,000USD25,766,000USD32,722,000USD32,908,000USD24,884,000USD
    Net Receivables—105,000USD713,000USD204,000USD6,100,000USD5,526,000USD5,624,000USD97,000USD
    Property Plant Equipment Gross—7,523,000USD7,858,000USD8,155,000USD45,327,000USD34,739,000USD31,273,000USD24,380,000USD
    Common Stock Shares Outstanding—10,499,000shares3,831,000shares612,250shares17,442shares391,240shares125,590shares37,852shares
    Non Current Assets Total—13,464,000USD13,062,000USD14,948,000USD54,336,000USD42,371,000USD32,441,000USD25,778,000USD
    Non Current Liabilities Total—2,199,000USD3,570,000USD4,244,000USD5,485,000USD31,755,000USD32,346,000USD24,671,000USD
    Non Currrent Assets Other—26,000USD1,322,000USD50,000USD7,730,000USD6,680,000USD24,000USD24,000USD
    Net Working Capital—3,615,000USD11,832,000USD4,677,000USD14,634,000USD97,952,000USD56,512,000USD1,350,000USD
    Unclassified Non Current Assets—1,308,000USD——-7,730,000USD-6,680,000USD——
    Unclassified Non Current Liabilities—2,199,000USD2,804,000USD3,717,000USD3,514,000USD31,755,000USD32,007,000USD24,671,000USD
    Unclassified Equity—347,066,000USD335,153,000USD304,281,000USD287,610,000USD282,049,000USD206,791,000USD108,275,000USD
    Long Term Debt——766,000USD———339,000USD—
    Other Liab———527,000USD1,971,000USD———
    Other Assets———2,009,000USD7,730,000USD6,680,000USD24,000USD24,000USD
    Short Term Investments———0USD10,845,000USD19,570,000USD0USD—
    Inventory———21,090,000USD3,900,000USD27,000USD798,000USD1USD
    Net Tangible Assets———9,993,000USD58,634,000USD107,633,000USD56,618,000USD1,089,000USD
    Unclassified Current Assets———-21,090,000USD————
    Unclassified Current Liabilities———-16,863,000USD-21,877,000USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20262026-06-30 · USDFY 20252025-06-30 · USDFY 20242024-06-30 · USDFY 20232023-06-30 · USDFY 20222022-06-30 · USDFY 20212021-06-30 · USDFY 20202020-06-30 · USDFY 20192019-06-30 · USD
    Depreciation578,000USD291,000USD1,250,000USD1,380,000USD3,791,000USD2,414,000USD2,241,000USD1,749,000USD
    Stock Based Compensation1,373,000USD1,530,000USD2,038,000USD4,391,000USD4,377,000USD1,586,000USD388,000USD241,000USD
    Deferred Income Tax-6,370,000USD———————
    Change To Account Receivables-65,000USD—0USD1,000,000USD4,214,000USD-10,738,000USD22,000USD-22,000USD
    Change To Liabilities5,337,000USD——-725,000USD1,246,000USD-1,339,000USD638,000USD210,000USD
    Change In Working Capital2,158,000USD479,000USD-3,168,000USD5,869,000USD3,243,000USD-11,154,000USD470,000USD1,453,000USD
    Operating Cash Flow-23,218,000USD———————
    Capital Expenditures-578,000USD-16,000USD-210,000USD-5,738,000USD-7,330,000USD-5,162,000USD-1,154,000USD-990,000USD
    Net Investments-31,496,000USD———————
    Unclassified Investing Cash Flow75,000USD——-7,009,000USD——1,230,000USD1,060,000USD
    Investing Cash Flow-31,999,000USD———————
    Net Debt Issuance-53,000USD———————
    Unclassified Financing Cash Flow103,101,000USD—25,523,000USD10,987,000USD—-78,276,000USD61,763,000USD—
    Financing Cash Flow103,048,000USD———————
    Change In Cash47,831,000USD-5,633,000USD6,846,000USD-21,093,000USD-54,728,000USD22,292,000USD50,691,000USD-11,513,000USD
    End Cash Flow56,623,000USD———————
    Net Income—-18,377,000USD-24,907,000USD-65,010,000USD-29,512,000USD-23,213,000USD-16,444,000USD-17,597,000USD
    Other Non Cash Items—773,000USD6,233,000USD167,000USD-15,324,000USD303,000USD-5,000USD179,000USD
    Total Cash From Operating Activities—-15,304,000USD-18,554,000USD-30,436,000USD-37,802,000USD-30,064,000USD-13,345,000USD-13,975,000USD
    Free Cash Flow—-15,320,000USD-18,764,000USD-36,174,000USD-45,132,000USD-35,226,000USD-14,499,000USD-14,965,000USD
    Investments—742,000USD906,000USD7,009,000USD-5,127,000USD-19,816,000USD-1,154,000USD-990,000USD
    Total Cashflows From Investing Activities—742,000USD906,000USD7,009,000USD-5,127,000USD-26,478,000USD-1,154,000USD-990,000USD
    Net Borrowings—-695,000USD-1,138,000USD-9,125,000USD-5,830,000USD-331,000USD-1,461,000USD-197,000USD
    Total Cash From Financing Activities—8,929,000USD24,494,000USD2,301,000USD-5,803,000USD78,835,000USD65,192,000USD3,453,000USD
    Sale Purchase Of Stock—0USD-7,000USD-39,000USD0USD—-40,803,000USD-159,000USD
    Issuance Of Capital Stock—3,541,000USD25,523,000USD11,487,000USD7,879,000USD78,276,000USD62,363,000USD1,350,000USD
    Begin Period Cash Flow—14,425,000USD7,579,000USD28,672,000USD77,404,000USD55,112,000USD4,421,000USD15,934,000USD
    End Period Cash Flow—8,792,000USD14,425,000USD7,579,000USD22,676,000USD77,404,000USD55,112,000USD4,421,000USD
    Other Cashflows From Investing Activities—758,000USD1,116,000USD12,747,000USD7,558,000USD-1,742,000USD-76,000USD-70,000USD
    Other Cashflows From Financing Activities—8,929,000USD116,000USD978,000USD-50,000USD79,166,000USD67,253,000USD3,650,000USD
    Change To Inventory——0USD-1,015,000USD-3,873,000USD772,000USD-798,000USD-96,000USD
    Dividends Paid———-500,000USD——-21,560,000USD—
    Unclassified Operating Cash Flow———22,767,000USD-4,377,000USD———
    Exchange Rate Changes——————-2,000USD-1,000USD
    Cash And Cash Equivalents Changes——————50,691,000USD-11,513,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20262026-03-31 · USDQ2 20262025-12-31 · USDQ1 20262025-09-30 · USDQ4 20252025-06-30 · USDQ3 20252025-03-31 · USDQ2 20252024-12-31 · USDQ1 20252024-09-30 · USDQ4 20242024-06-30 · USD
    Net Income-7,730,000USD-8,993,000USD-5,720,000USD-5,163,000USD-4,861,000USD-4,364,000USD-3,989,000USD-7,778,000USD
    Depreciation250,000USD-211,000USD289,000USD285,000USD282,000USD281,000USD278,000USD281,000USD
    Stock Based Compensation377,000USD253,000USD323,000USD270,000USD370,000USD475,000USD415,000USD360,000USD
    Other Non Cash Items2,789,000USD2,918,000USD-28,000USD-15,000USD-14,000USD-14,000USD-19,000USD4,531,000USD
    Change To Account Receivables0USD0USD-65,000USD—0USD0USD0USD0USD
    Change In Working Capital-1,393,000USD792,000USD-529,000USD8,000USD1,118,000USD-247,000USD-400,000USD-2,248,000USD
    Total Cash From Operating Activities-6,084,000USD-5,241,000USD-5,665,000USD-4,615,000USD-3,105,000USD-3,869,000USD-3,715,000USD-4,854,000USD
    Capital Expenditures-11,000USD-516,000USD-32,000USD-1,000USD-14,000USD-1,000USD0USD-210,000USD
    Free Cash Flow-6,095,000USD-5,757,000USD-5,697,000USD-4,616,000USD-3,119,000USD-3,870,000USD-3,715,000USD-5,064,000USD
    Investments-3,100,000USD-2,467,000USD-21,493,000USD45,000USD-14,000USD-2,000USD713,000USD-144,000USD
    Total Cashflows From Investing Activities-3,111,000USD-2,983,000USD-21,493,000USD45,000USD-14,000USD-2,000USD713,000USD-144,000USD
    Net Borrowings0USD-614,000USD-160,000USD-183,000USD-176,000USD-170,000USD-166,000USD—
    Total Cash From Financing Activities28,154,000USD8,785,000USD46,705,000USD8,180,000USD1,063,000USD-152,000USD-162,000USD12,992,000USD
    Issuance Of Capital Stock3,310,000USD0USD219,000USD2,410,000USD1,127,000USD0USD4,000USD14,232,000USD
    Change In Cash18,959,000USD561,000USD19,529,000USD3,610,000USD-2,056,000USD-4,023,000USD-3,164,000USD7,994,000USD
    Begin Period Cash Flow28,672,000USD28,111,000USD8,582,000USD5,182,000USD7,238,000USD11,038,000USD14,425,000USD6,431,000USD
    End Period Cash Flow47,631,000USD28,672,000USD28,111,000USD8,792,000USD5,182,000USD7,015,000USD11,261,000USD14,425,000USD
    Other Cashflows From Investing Activities-3,100,000USD21,461,000USD-21,461,000USD46,000USD—-1,000USD713,000USD66,000USD
    Other Cashflows From Financing Activities28,154,000USD8,785,000USD105,000USD5,953,000USD112,000USD18,000USD713,000USD-1,000USD
    Unclassified Investing Cash Flow3,100,000USD-21,461,000USD21,493,000USD—————
    Unclassified Financing Cash Flow-3,310,000USD—46,541,000USD2,410,000USD1,127,000USD——12,947,000USD
    Sale Purchase Of Stock———0USD0USD——46,000USD
    Change To Inventory———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    FY 2022Yearly · 2022-06-30SegmentIbio Cdmo499,000USD0001420720-22-000064
    FY 2022Yearly · 2022-06-30SegmentIbio Inc1,884,000USD0001420720-22-000064
    Q3 2022Quarterly · 2022-03-31SegmentIbio Cdmo143,000USD0001420720-22-000024
    Q3 2022Quarterly · 2022-03-31SegmentIbio Inc1,800,000USD0001420720-22-000024
    Q1 2022Quarterly · 2021-09-30SegmentIbio Cdmo127,000USD0001558370-21-015986
    Q1 2022Quarterly · 2021-09-30SegmentIbio Inc84,000USD0001558370-21-015986
    FY 2021Yearly · 2021-06-30SegmentIbio Cdmo1,274,000USD0001420720-22-000064
    FY 2021Yearly · 2021-06-30SegmentIbio Inc1,098,000USD0001420720-22-000064
    Q4 2021Quarterly · 2021-06-30SegmentIbio Cdmo491,000USDLegacy provider
    Q4 2021Quarterly · 2021-06-30SegmentIbio Inc1,000USDLegacy provider
    Q3 2021Quarterly · 2021-03-31SegmentIbio Cdmo65,000USD0001420720-22-000024
    Q3 2021Quarterly · 2021-03-31SegmentIbio Inc700,000USD0001420720-22-000024
    Q2 2021Quarterly · 2020-12-31SegmentIbio Cdmo515,000USD0001558370-22-001104
    Q2 2021Quarterly · 2020-12-31SegmentIbio Inc190,000USD0001558370-22-001104
    Q1 2021Quarterly · 2020-09-30SegmentIbio Cdmo203,000USD0001558370-21-015986
    Q1 2021Quarterly · 2020-09-30SegmentIbio Inc207,000USD0001558370-21-015986
    FY 2020Yearly · 2020-06-30SegmentIbio Cdmo92,000USD0001558370-21-012819
    FY 2020Yearly · 2020-06-30SegmentIbio Inc1,546,000USD0001558370-21-012819
    Q4 2020Quarterly · 2020-06-30SegmentIbio Cdmo0USDLegacy provider
    Q4 2020Quarterly · 2020-06-30SegmentIbio Inc1,121,000USDLegacy provider
    Q3 2020Quarterly · 2020-03-31SegmentIbio Cdmo21,000USD0001558370-21-007415
    Q3 2020Quarterly · 2020-03-31SegmentIbio Inc75,000USD0001558370-21-007415
    FY 2019Yearly · 2019-06-30SegmentIbio Cdmo0USD0001104659-20-114567
    FY 2019Yearly · 2019-06-30SegmentIbio Inc2,018,000USD0001104659-20-114567
    FY 2018Yearly · 2018-06-30SegmentIbio Cdmo37,000USD0001144204-19-041659
    FY 2018Yearly · 2018-06-30SegmentIbio Inc407,000USD0001144204-19-041659
    FY 2017Yearly · 2017-06-30SegmentIbio Cdmo123,000USD0001144204-18-049866
    FY 2017Yearly · 2017-06-30SegmentIbio Inc271,000USD0001144204-18-049866
    FY 2016Yearly · 2016-06-30SegmentIbio Cdmo55,000USD0001144204-17-048249
    FY 2016Yearly · 2016-06-30SegmentIbio Inc893,000USD0001144204-17-048249

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.